Failure of cyanide to antagonize sodium nitroprusside in vivo in dogs
Related Experiment Video
Updated: Jul 16, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Abstract:
The role of cyanide (CN) in the mechanism of action of sodium nitroprusside (SNP) has not been well defined. Some authors consider accumulation of CN in muscle to be the principal factor responsible for resistance to SNP when given to induce hypotension. To test this hypothesis, SNP was infused in 12 anesthetized dogs. Mean aortic blood pressure was reduced 50% and dogs were maintained at this pressure for 5 minutes. After recovery, eight of the dogs (group 1) received a potassium cyanide (KCN) infusion at a rate of 0.0125 mg/kg/min for 180 minutes; the other four dogs (group 2) were given saline solution and served as controls. After 180 minutes, all 12 dogs received a second infusion of SNP in the same dose as their first. No significant differences in blood pressure or heart rate were observed between groups. Left ventricular end-diastolic pressure (LVEDP) and dP/dt were elevated following KCN; however, after the second SNP infusion these parameters decreased in both groups. Cardiac output (Qt) decreased to 55% of baseline during the first SNP infusion and showed no significant changes during the second SNP infusion, but total peripheal resistance decreased significantly during both SNP infusions. Although whole-blood CN levels and gracilis muscle tissue CN concentrations were significantly greater (p < 0.05) in group 1 after KCN, the cardiovascular effects of SNP were not significantly altered by these increases in KCN, the cardiovascular effects of SNP were not significantly altered by these increases in CN. The authors conclude that resistance to SNP in induced hypotension is not the result of direct effects of CN on smooth muscle.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
08:21Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
Related Concept Videos
2° Amines to N-Nitrosamines: Reaction with NaNO2
Antihypertensive Drugs: Vasodilators
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...